Provider and Caregiver Satisfaction with Telehealth Evaluation of Autism Spectrum Disorder in Young Children During the COVID-19 Pandemic.
Autor: | Reisinger DL; Department of Pediatrics, Indiana University School of Medicine, 1002 Wishard Blvd, Suite 3120, 46202, Indianapolis, IN, United States. dlreisin@iu.edu., Hines E; Department of Pediatrics, Indiana University School of Medicine, 1002 Wishard Blvd, Suite 3120, 46202, Indianapolis, IN, United States., Raches C; Department of Pediatrics, Indiana University School of Medicine, 1002 Wishard Blvd, Suite 3120, 46202, Indianapolis, IN, United States., Tang Q; Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana, United States., James C; Department of Pediatrics, Indiana University School of Medicine, 1002 Wishard Blvd, Suite 3120, 46202, Indianapolis, IN, United States., Keehn RM; Department of Pediatrics, Indiana University School of Medicine, 1002 Wishard Blvd, Suite 3120, 46202, Indianapolis, IN, United States. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of autism and developmental disorders [J Autism Dev Disord] 2022 Dec; Vol. 52 (12), pp. 5099-5113. Date of Electronic Publication: 2022 May 17. |
DOI: | 10.1007/s10803-022-05576-1 |
Abstrakt: | The present study examines provider and caregiver satisfaction with telehealth evaluation of autism spectrum disorder (ASD) in young children during the coronavirus SARS-CoV-2 (COVID-19) pandemic. A telehealth model of ASD evaluation was implemented with 308 children ages 14 to 78 months between May 2020 to June 2021. Data were gathered from electronic health records, autism-specific telehealth diagnostic tools, and post-evaluation surveys. Overall, the majority of providers and caregivers were satisfied with telehealth ASD evaluation. Multiple variables were associated with ratings of satisfaction, differing by providers and caregivers. Findings have important implications for the feasibility and acceptability of telehealth ASD evaluations, in addition to key factors to consider in optimizing and sustaining telehealth evaluations beyond the COVID-19 pandemic. (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |